About Metagenomi, Inc. 
Metagenomi, Inc.
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates 
No Company Details Available
Shareholding Snapshot
Shareholding Compare (%holding) 
Majority shareholders
Domestic Funds
Domestic Funds
Held in 15 Schemes (9.85%)
Foreign Institutions
Held by 19 Foreign Institutions (9.23%)
Strategic Entities with highest holding
Highest Public shareholder
Management
Designation
No Data
Revenue and Profits:
Net Sales:
9 Million
(Quarterly Results - Jun 2025)
Net Profit:
-20 Million
Pharmaceuticals & Biotechnology
USD 70 Million (Micro Cap)
NA (Loss Making)
NA
0.00%
-1.02
-39.14%
0.36






